Biotech Eiger Says Ch. 11 Should Stay In Texas
Rare-disease treatment developer Eiger has urged a Texas bankruptcy judge to keep its Chapter 11 in the Dallas court despite an attempt by the U.S. Trustee's Office to have the case...To view the full article, register now.
Already a subscriber? Click here to view full article